Needham analyst Mike Matson raised the firm’s price target on Axonics to $76 from $73 and keeps a Buy rating on the shares. The company’s reported a Q2 adjusted EBITDA beat and its new R20 SNM system launched in March 2023, combined with direct-to-consumer ad campaign, remained the key drivers of its strong revenue growth, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AXNX: